Massive Bio
Latest round
- Seed
Last raised
- Apr 2019
Total raised
- $3.6M
Investors
- 2
About Massive Bio
Founded in 2014 in New York, US, Massive Bio focuses on revolutionizing the clinical trial process for cancer patients.Massive Bio offers an AI-powered platform that connects cancer patients with clinical trials, streamlining the matching process regardless of geographical location or financial constraints. Patients can share their medical history and receive instant feedback on eligibility for over 19,000 clinical trials worldwide. The platform integrates physician expertise with advanced algorithms, ensuring a tailored approach.Massive Bio generates revenue through partnerships and subscription models targeting healthcare providers and patients. Their platform facilitates healthcare professionals in identifying suitable clinical trials, subsequently increasing referral rates and improving patient management. Revenue streams also arise from direct engagement with pharmaceutical companies and contract research organizations (CROs) seeking patient recruitment for ongoing trials. The company is also targeting expansion into new geographic markets, particularly in Europe and Asia, by 2024, aiming to increase accessibility to its services and further support cancer patients worldwide.
Who invested in Massive Bio
2 investors across 2 rounds
See all investors in Massive Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Massive Bio
Who invested in Massive Bio?
Massive Bio has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Massive Bio raised?
Massive Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Massive Bio last raise money?
Massive Bio's most recent round on record is a Seed, in Apr 2019.
What does Massive Bio do?
Founded in 2014 in New York, US, Massive Bio focuses on revolutionizing the clinical trial process for cancer patients.
Where is Massive Bio headquartered?
Massive Bio is headquartered in New York, US.
Which VCs invest in companies like Massive Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Massive Bio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Massive Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.